BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 31731424)

  • 1.
    Dutta R; Khalil R; Green R; Mohapatra SS; Mohapatra S
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
    Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
    J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
    Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
    J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
    [No Abstract]   [Full Text] [Related]  

  • 4. Withaferin A-A Promising Phytochemical Compound with Multiple Results in Dermatological Diseases.
    Bungau S; Vesa CM; Abid A; Behl T; Tit DM; Purza AL; Pasca B; Todan LM; Endres L
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33919088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorinated and diepoxy withanolides from Withania somnifera and their cytotoxic effects against human lung cancer cell line.
    Choudhary MI; Hussain S; Yousuf S; Dar A; Mudassar ; Atta-ur-Rahman
    Phytochemistry; 2010 Dec; 71(17-18):2205-9. PubMed ID: 21044792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular targets and mechanisms of cancer prevention and treatment by withaferin a, a naturally occurring steroidal lactone.
    Vyas AR; Singh SV
    AAPS J; 2014 Jan; 16(1):1-10. PubMed ID: 24046237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hedgehog inhibitors from Withania somnifera.
    Yoneyama T; Arai MA; Sadhu SK; Ahmed F; Ishibashi M
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3541-4. PubMed ID: 26169123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical assessment of the whole plant-based phytotherapeutics from
    Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
    Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
    [No Abstract]   [Full Text] [Related]  

  • 9. In Silico Elucidation of the Plausible Inhibitory Potential of Withaferin A of Withania Somnifera Medicinal Herb Against Breast Cancer Targeting Estrogen Receptor.
    Ali MA; Farah MA; Al-Anazi KM; Basha SH; Bai F; Lee J; Al-Hemaid FMA; Mahmoud AH; Hailan WAQ
    Curr Pharm Biotechnol; 2020; 21(9):842-851. PubMed ID: 31995002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
    Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
    J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
    Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.
    Rai M; Jogee PS; Agarkar G; dos Santos CA
    Pharm Biol; 2016; 54(2):189-97. PubMed ID: 25845640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.
    Hahm ER; Kim SH; Singh KB; Singh K; Singh SV
    Cancer Prev Res (Phila); 2020 Sep; 13(9):721-734. PubMed ID: 32727824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
    Purushotham PM; Kim JM; Jo EK; Senthil K
    Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
    Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
    Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keeping abreast about ashwagandha in breast cancer.
    Vashi R; Patel BM; Goyal RK
    J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Perspective on
    Dubey S; Singh M; Nelson A; Karan D
    J Immunol Res; 2021; 2021():9483433. PubMed ID: 34485538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withaferin A and its potential role in glioblastoma (GBM).
    Dhami J; Chang E; Gambhir SS
    J Neurooncol; 2017 Jan; 131(2):201-211. PubMed ID: 27837436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5,6-de-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves.
    Siddique AA; Joshi P; Misra L; Sangwan NS; Darokar MP
    Nat Prod Res; 2014; 28(6):392-8. PubMed ID: 24422976
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Lee DH; Ahn J; Jang YJ; Seo HD; Ha TY; Kim MJ; Huh YH; Jung CH
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32046183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.